Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study.

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

September 8, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Myeloproliferative DiseaseInflammatory Markers
Trial Locations (11)

Unknown

RECRUITING

Azienda Ospedaliera Universitaria Consorziale Policlinico, Bari

RECRUITING

Policlinico Sant'Orsola Malpighi, Bologna

RECRUITING

ASST Spedali Civili di Brescia, Brescia

RECRUITING

Policlinico Vittorio Emanuele, Catania

RECRUITING

Ospedale Universitario Federico II, Napoli

RECRUITING

Policlinico Umberto I, Università La Sapienza, Roma

RECRUITING

Azienda Ospedaliera Universitaria Città della Salute e delle Scienza, Torino

RECRUITING

Ospedale San Luigi di Orbassano - Ospedale Mauriziano, Torino

RECRUITING

Azienda Ospedaliera Universitaria Friuli Centrale, Udine

RECRUITING

Azienda Ospedaliera Universitaria Integrata, Verona

RECRUITING

Ospedale Belcolle, Viterbo

All Listed Sponsors
lead

University of Milano Bicocca

OTHER

NCT05553873 - Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study. | Biotech Hunter | Biotech Hunter